BELMONT MEDICAL TECHNOLOGY

RI-2 Fluid Management System End of Functional Life Notice

End of Functional Life Notice

1 Page

780 BOSTON ROAD BILLERICA, MA 01821, USA T 978.663.0212 | F 978.663.0214 BELMONTMEDTECH.COM  Billerica MA, August 21st 2024 Important information about Belmont Rapid Infuser RI-2 equipment older than 7 years after the date of manufacture End-of-Service-Life (EoSL) is defined by factors such as how equipment is registered with medical device regulatory bodies, the results of testing conducted during the registration process, the risk of component supplier obsolescence and observance of international RoHS guidelines. EoSL for the Belmont Rapid Infuser RI-2 is 7 years after the date of manufacture, after which no further Preventative Maintenance (PM) or repairs will be performed. Therefore, a Belmont Rapid Infuser RI-2 older than 7 years can be used until its next PM. But, as no further PM will be performed either by Belmont or by Getz, the equipment should be replaced. The use of such equipment without a valid PM is at the user’s risk and responsibility. Neither Belmont nor Getz Healthcare are liable for any deviation from the manufacturer’s instructions. Spare parts are unavailable to repair such equipment. Both your local Getz representative and Getz Healthcare Technical Services can help you understand which of your Belmont units are older than 7 years and assist you in transitioning to the latest version of the Belmont Rapid Infuser RI-2. For further information, please contact: Australia: 1300 654 552 New Zealand: 0800 733 333 Sincerely,  Venceslao Benanzio Director, International Distributor Sales Belmont Medical Technologies +1.978.663.0212  BELMONT MEDICAL TECHNOLOGIES | 780 BOSTON ROAD, BILLERICA, MA 01821 | T 978.663.0212 | BELMONTMEDTECH.COM
File Type: PDF
File Size: 213 KB
File Name: BELMONT MEDICAL TECHNOLOGY - RI-2 Fluid Management System End of Functional Life Notice - 2024-08.pdf

By clicking Download you are confirming this is the correct document for your purposes
and that you agree to our Terms & Conditions